Question 1

Who is Capital Management, L.p. Ra?

Accepted Answer

Capital Management, L.p. Ra serves as Executive at Phathom Pharmaceuticals, Inc. (PHAT). They have executed 101 insider transactions totaling $453.5M over their tenure at the company.

Question 2

What is Capital Management, L.p. Ra's role at Phathom Pharmaceuticals, Inc.?

Accepted Answer

Capital Management, L.p. Ra holds the position of Executive at Phathom Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.

Question 3

Is Capital Management, L.p. Ra buying or selling PHAT stock?

Accepted Answer

Capital Management, L.p. Ra has shown a buying trading pattern, with $431.9M in total purchases and $21.6M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.

Question 4

What are Capital Management, L.p. Ra's largest insider transactions?

Accepted Answer

The largest transaction by Capital Management, L.p. Ra was on Dec 18, 2025, when they purchased $50.0M worth of VOR shares. This transaction involved 4,625,346 shares at $10.81 per share.

Question 5

What is Capital Management, L.p. Ra's trading accuracy?

Accepted Answer

Capital Management, L.p. Ra has a Personal Accuracy Score of 78/100, which measures the historical performance of their insider transactions. This score is calculated based on the timing and performance of their trades relative to market movements.

Question 6

How many companies is Capital Management, L.p. Ra associated with?

Accepted Answer

Capital Management, L.p. Ra has filed Form 4 transactions for 11 different companyies. Their primary association is with Phathom Pharmaceuticals, Inc. (PHAT), where they serve as Executive.

Question 7

How much PHAT stock does Capital Management, L.p. Ra own?

Accepted Answer

Capital Management, L.p. Ra currently owns 8,300 shares of Phathom Pharmaceuticals, Inc. (PHAT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.

Question 8

What is Capital Management, L.p. Ra's equity in Phathom Pharmaceuticals, Inc.?

Accepted Answer

Capital Management, L.p. Ra's equity position in Phathom Pharmaceuticals, Inc. consists of 8,300 shares valued at approximately $0. As Executive, they have executed 101 insider transactions, with $431.9M in purchases and $21.6M in sales.

Question 9

Where can I find Capital Management, L.p. Ra's SEC Form 4 filings?

Accepted Answer

All of Capital Management, L.p. Ra's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Capital Management, L.p. Ra has 101 Form 4 filings on record as an insider at Phathom Pharmaceuticals, Inc..

Question 10

What is Capital Management, L.p. Ra's net worth from PHAT?

Accepted Answer

Based on their current PHAT stock holdings, Capital Management, L.p. Ra has equity worth approximately $0 in Phathom Pharmaceuticals, Inc.. This value is based on 8,300 shares at current market prices and does not represent their total net worth, which may include other assets and investments.

DATE	TICKER	VALUE	TYPE	SHARES	PRICE	10b5-1
Feb 19, 2026	MLYS	$0	Award	8,300	$N/A	Discretionary
Feb 19, 2026	MLYS	$0	Award	6,200

Capital Management, L.p. Ra

Position Evolution

Equity Curve

Trading Analytics

Recent Transactions

Largest Transactions

Companies Associated

Capital Management, L.p. Ra Trading Summary

How Much PHAT Stock Does Capital Management, L.p. Ra Own?

Is Capital Management, L.p. Ra Buying or Selling PHAT?

Capital Management, L.p. Ra's Recent Stock Transactions

Frequently Asked Questions

Track Capital Management, L.p. Ra's Trades